Provider
DPP-4 Inhibitors and Combinations - Medicaid
Step Therapy, Quantity Limit
Program effective Date: May 01, 2026
Documents & Forms Results
Displaying 3621 - 3630 of 3677 results
Provider
DPP-4 Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Topiramate ER - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Vykat XR - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Xdemvy - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Quantity Limit
Program effective Date: May 01, 2026
Provider
Vtama (tapinarof) - Commercial
Prior Authorization
Program effective Date: May 01, 2026
Provider
PCSK9 Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Selective Serotonin Inverse Agonist (SSIA) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Hetlioz (tasimelteon) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026